LABCORP HOLDINGS INC (LH) Stock Price & Overview

NYSE:LH • US5049221055

280.85 USD
-2.14 (-0.76%)
At close: Mar 4, 2026
280.85 USD
0 (0%)
After Hours: 3/4/2026, 8:04:00 PM

The current stock price of LH is 280.85 USD. Today LH is down by -0.76%. In the past month the price increased by 3.18%. In the past year, price increased by 10.99%.

LH Key Statistics

52-Week Range209.375 - 293.72
Current LH stock price positioned within its 52-week range.
1-Month Range260.57 - 292.02
Current LH stock price positioned within its 1-month range.
Market Cap
23.282B
P/E
17.08
Fwd P/E
15.59
EPS (TTM)
16.44
Dividend Yield
1.00%

LH Stock Performance

Today
-0.76%
1 Week
-0.68%
1 Month
+3.18%
3 Months
+8.69%
Longer-term
6 Months +0.78%
1 Year +10.99%
2 Years +28.56%
3 Years +22.42%
5 Years +10.12%
10 Years +139.78%

LH Stock Chart

LABCORP HOLDINGS INC / LH Daily stock chart

LH Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to LH. When comparing the yearly performance of all stocks, LH turns out to be only a medium performer in the overall market: it outperformed 63.53% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
LH Full Technical Analysis Report

LH Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to LH. LH has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
LH Full Fundamental Analysis Report

LH Earnings

On February 17, 2026 LH reported an EPS of 4.07 and a revenue of 3.52B. The company beat EPS expectations (0.26% surprise) and missed revenue expectations (-4.07% surprise).

Next Earnings DateApr 27, 2026
Last Earnings DateFeb 17, 2026
PeriodQ4 / 2025
EPS Reported$4.07
Revenue Reported3.516B
EPS Surprise 0.26%
Revenue Surprise -4.07%
LH Earnings History

LH Forecast & Estimates

29 analysts have analysed LH and the average price target is 309.93 USD. This implies a price increase of 10.36% is expected in the next year compared to the current price of 280.85.

For the next year, analysts expect an EPS growth of 9.56% and a revenue growth 4.51% for LH


Analysts
Analysts82.76
Price Target309.93 (10.35%)
EPS Next Y9.56%
Revenue Next Year4.51%
LH Forecast & Estimates

LH Groups

Sector & Classification

LH Financial Highlights

Over the last trailing twelve months LH reported a non-GAAP Earnings per Share(EPS) of 16.44. The EPS increased by 12.83% compared to the year before.


Income Statements
Revenue(TTM)13.95B
Net Income(TTM)876.50M
Industry RankSector Rank
PM (TTM) 6.28%
ROA 4.77%
ROE 10.17%
Debt/Equity 0.6
Chartmill High Growth Momentum
EPS Q2Q%17.97%
Sales Q2Q%5.6%
EPS 1Y (TTM)12.83%
Revenue 1Y (TTM)7.25%
LH financials

LH Ownership

Ownership
Inst Owners98.13%
Shares82.90M
Float82.58M
Ins Owners0.31%
Short Float %3.65%
Short Ratio4
LH Ownership

LH Latest News, Press Relases and Analysis

All LH news

LH Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
CVS CVS HEALTH CORP11.13102.278B
CI THE CIGNA GROUP9.1175.018B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27101.327.19B
DGX QUEST DIAGNOSTICS INC19.8323.188B
GH GUARDANT HEALTH INC N/A11.985B
DVA DAVITA INC11.710.611B
BTSG BRIGHTSPRING HEALTH SERVICES30.268.121B
CHE CHEMED CORP16.955.659B
RDNT RADNET INC89.665.52B
OPCH OPTION CARE HEALTH INC16.114.806B
HIMS HIMS & HERS HEALTH INC30.123.75B
BLLN BILLIONTOONE INC CL A281.383.7B

About LH

Company Profile

LH logo image Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 70,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

Company Info

LABCORP HOLDINGS INC

358 S Main St

Burlington NORTH CAROLINA 27215 US

CEO: Adam H. Schechter

Employees: 70000

LH Company Website

LH Investor Relations

Phone: 13362291127

LABCORP HOLDINGS INC / LH FAQ

What does LABCORP HOLDINGS INC do?

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 70,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.


What is the current price of LH stock?

The current stock price of LH is 280.85 USD. The price decreased by -0.76% in the last trading session.


Does LH stock pay dividends?

LABCORP HOLDINGS INC (LH) has a dividend yield of 1%. The yearly dividend amount is currently 2.91.


What is the ChartMill rating of LABCORP HOLDINGS INC stock?

LH has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What sector and industry does LABCORP HOLDINGS INC belong to?

LABCORP HOLDINGS INC (LH) operates in the Health Care sector and the Health Care Providers & Services industry.


Is LABCORP HOLDINGS INC (LH) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LH.


What is the outstanding short interest for LABCORP HOLDINGS INC?

The outstanding short interest for LABCORP HOLDINGS INC (LH) is 3.65% of its float.